Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

AstraZeneca lifts FTSE 100 to its best session in one week

Published 29/09/2021, 08:24
Updated 29/09/2021, 16:56
© Reuters. FILE PHOTO: The London Stock Exchange Group offices are seen in the City of London, Britain, December 29, 2017. REUTERS/Toby Melville/File Photo

© Reuters. FILE PHOTO: The London Stock Exchange Group offices are seen in the City of London, Britain, December 29, 2017. REUTERS/Toby Melville/File Photo

By Bansari Mayur Kamdar, Shashank Nayar and Amal S

(Reuters) -London's FTSE 100 ended higher on Wednesday, as AstraZeneca (NASDAQ:AZN) boosted healthcare stocks on completing a takeover deal to sharpen its focus on rare-disease drugs.

AstraZeneca rose 4.2% and was the top boost to the blue-chip FTSE 100 after the pharmaceutical company said its newly acquired Alexion (NASDAQ:ALXN) division would buy the remaining equity in Caelum Biosciences in a deal that could be worth up to $500 million.

The FTSE 100 rose 1.1% to mark its best day in a week. HSBC Holdings (LON:HSBA) advanced 2.1% and led the banking sub-index 1.7% higher, while Investec, Natwest Group and Lloyds (LON:LLOY) rose between 0.7% and 2.2%.

The blue-chip index has risen 10.1% so far this year on highly accommodative central bank policies and optimism around steady COVID-19 vaccination drives. But in September, it is set to record its worst month since January this year as inflation and economic slowdown worries weighed on investor sentiment.

"To counter the threat posed by rising prices they (central banks) face the prospect of dialling down economic support at a time of mounting uncertainty over the recovery," said Russ Mould, investment director at AJ Bell.

The benchmark UK 10-year bond yield slipped on Wednesday but has gained nearly 50 basis points in the past eight trading sessions, as signs of a more persistent inflation pattern raised bets of a sooner-than-expected interest rate hike. Banks generally perform better in a higher interest rate environment.

Britons have reported a first worsening in their financial situation in more than a year as inflation pushes up the cost of living, a survey showed.

The domestically focussed mid-cap index advanced 0.1%, with travel and leisure stocks among the top gainers.

Among stocks, clothing retailer Next Plc rose 3.9% after raising its full-year profit guidance.

© Reuters. FILE PHOTO: The London Stock Exchange Group offices are seen in the City of London, Britain, December 29, 2017. REUTERS/Toby Melville/File Photo

Upper Crust owner SSP Group fell 5.4% over a slow recovery as sales remained at half of the pre-pandemic levels.

Morrisons gained 1.4% on report that a $9.5-billion fight for the British supermarket will be decided at an auction on Saturday.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.